Loss of HER2 after HER2-targeted treatment
Loss of HER2 after HER2-targeted treatment
About this item
Full title
Loss of HER2 after HER2-targeted treatment
Author / Creator
Publisher
New York: Springer US
Journal title
Breast cancer research and treatment, 2019-06, Vol.175 (2), p.401-408
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose
HER2 expression has been reported to be discordant between primary tumor and metastatic tissue.
Patients and methods
HER2 discordance and relation to HER2-targeted treatment was investigated in 227 patients with primary breast cancer.
Results
HER2 discordance between primary biopsy and second biopsy after neoadjuvant or adjuv...
Alternative Titles
Full title
Loss of HER2 after HER2-targeted treatment
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2186149256
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2186149256
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-019-05173-4
